ResMed(RMD) - 2022 Q1 - Earnings Call Transcript

ResMed Inc. (NYSE:RMD) Q1 2022 Earnings Conference Call October 28, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President, Investor Relations & Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer Rob Douglas - President and Chief Operating Officer Jim Hollingshead - President, Sleep & Respiratory Care business Conference Call Participants Matthew Mishan - KeyBanc Chris Cooper - Goldman Sachs David Low - JPMorgan Suraj Kalia - Oppenheimer Gre ...